Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.

U.S. Court of Appeals for the Federal Circuit

Otsuka Pharmaceutical Co., Ltd. v. Sandoz, Inc.

Opinion

United States Court of Appeals for the Federal Circuit ______________________

June 13, 2012

ERRATUM ______________________

Appeal Nos. 2011-1126, -1127

OTSUKA PHARMACEUTICAL CO., LTD.,

Plaintiff-Appellee,

v.

SANDOZ, INC., SUN PHARMACEUTICAL INDUSTRIES, LTD., SYNTHON BV, SYNTHON HOLDINGS BV, SYNTHON LABORATORIES, INC., and SYNTHON PHARMACEUTICALS, INC.,

Defendants,

and

APOTEX INC. and APOTEX CORP.,

Defendants-Appellants,

and TEVA PHARMACEUTICALS USA, INC., BARR LABORATORIES, INC., and BARR PHARMACEUTICALS, INC.,

Defendants-Appellants.

Decided: May 7, 2012 Precedential Opinion ______________________

The following change has been made:

Page 21, line 4, “marketed” has been changed to -- promising--.

Reference

Status
Published